基本信息
浏览量:4
职业迁徙
个人简介
Richard Vile, Ph.D., and his research team develop experimental cancer therapies, all based on stimulating antitumor immune responses.
Dr. Vile's research combines in vivo and in vitro assays, but predominantly focuses in murine immune-competent models and syngeneic tumors. Although his team has a major interest in melanoma, they also have models of prostate cancer, glioma and brain metastases, and can be applied across tumor sites.
研究兴趣
论文共 199 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Mason J Webb,Timothy Kottke,Benjamin L Kendall, Jack Swanson,Chisom Uzendu,Jason Tonne,Jill Thompson, Muriel Metko,Madelyn Moore,Mitesh Borad,Lewis Roberts,Rosa M Diaz,
Molecular therapy oncolytics (2023): 129-142
引用0浏览0WOS引用
0
0
Luke Kendall,Richard G. Vile
Molecular Therapy - Oncolytics (2023): 42-43
Pharmaceuticals (Basel, Switzerland)no. 6 (2023)
引用0浏览0WOS引用
0
0
biorxiv(2022)
Laura Evgin,Tim Kottke,Jason Tonne,Jill Thompson,Amanda L Huff,Jacob van Vloten,Madelyn Moore, Josefine Michael,Christopher Driscoll,Jose Pulido, Eric Swanson,Richard Kennedy,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn